Agency Forms Undergoing Paperwork Reduction Act Review, 65578-65580 [E7-22731]
Download as PDF
<![CDATA[
65578
Federal Register / Vol. 72, No. 224 / Wednesday, November 21, 2007 / Notices
pwalker on PROD1PC71 with NOTICES
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than December 17,
2007.
A. Federal Reserve Bank of Kansas
City (Todd Offenbacker, Assistant Vice
President) 925 Grand Avenue, Kansas
City, Missouri 64198–0001:
1. Harker Investments, LLLP, Denver,
Colorado; to become a bank holding
company by acquiring 100 percent of
the voting shares of The Kit Carson
Insurance Agency, Inc., and thereby
acquire Kit Carson State Bank, both in
Kit Carson, Colorado.
In connection with this application,
Applicant also has applied to engage in
selling credit life insurance, pursuant to
section 225.28(b)(11)(i) of Regulation Y.
B. Federal Reserve Bank of San
Francisco (Tracy Basinger, Director,
Regional and Community Bank Group)
101 Market Street, San Francisco,
California 94105–1579:
1. RiverBank Holding Company; to
become a bank holding company by
acquiring 100 percent of the voting
shares of RiverBank, both of Spokane,
Washington.
Board of Governors of the Federal Reserve
System, November 16, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.E7–22735 Filed 11–20–07; 8:45 am]
BILLING CODE 6210–01–S
VerDate Aug<31>2005
16:56 Nov 20, 2007
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Meeting
ACTION:
Announcement of meeting.
This notice announces the
18th meeting of the American Health
Information Community in accordance
with the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., App.)
The American Health Information
Community will advise the Secretary
and recommend specific actions to
achieve a common interoperability
framework for health information
technology (IT).
DATES: November 28, 2007, time to be
determined. Check Web site for further
information for dialing into meeting for
public comment.
ADDRESSES: This will be a conference
call meeting only. Public comment will
be taken at the conclusion of the
meeting.
SUMMARY:
For
further information, visit https://
www.hhs.gov/healthit/ahic.html.
SUPPLEMENTARY INFORMATION: This
special meeting has been called to
discuss a recommendation to the
Community from its Electronic Health
Records Workgroup (EHR WG) on the
Centers for Medicare and Medicaid
Services’ (CMS) authority to require eprescribing.
FOR FURTHER INFORMATION CONTACT:
Dated: November 15, 2007.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 07–5791 Filed 11–16–07; 4:11 pm]
BILLING CODE 4150–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–07–0666]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
National Healthcare Safety Network
(OMB Control No. 0920–0666)—
Revision—National Center for
Preparedness, Detection and Control of
Infectious Diseases (NCPDCID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and to promote
healthcare safety. Specifically, the data
is used to determine the magnitude of
various healthcare-associated adverse
events and trends in the rates of these
events among patients and healthcare
workers with similar risks. The data will
be used to detect changes in the
epidemiology of adverse events
resulting from new and current medical
therapies and changing risks.
Healthcare institutions that
participate in NHSN voluntarily report
their data to CDC using a web browserbased technology for data entry and data
management. Data are collected by
trained surveillance personnel using
written standardized protocols. This
application to OMB includes a
significant increase in the number of
burden hours to the previously
approved data collection. The increase
is due to inclusion of new forms and an
increased number of respondents.
NHSN was first approved by OMB in
2005 and CDC proposes to revise this
data collection by adding new modules
to the NHSN as well as modifying
currently approved forms. Four new
forms are proposed: (1) Healthcare
Worker Influenza Vaccination form; (2)
Healthcare Worker Influenza Antiviral
Medication Administration form; (3)
Pre-season survey on Influenza
Vaccination Programs for Healthcare
Workers; and (4) Post-season Survey on
Influenza Vaccination Programs for
Healthcare Workers. The purpose of
these new forms is to help participating
healthcare institutions and CDC to: (1)
Monitor influenza vaccination coverage
among healthcare personnel at
individual facilities and to provide
aggregate coverage estimates for all
E:\FR\FM\21NON1.SGM
21NON1
Federal Register / Vol. 72, No. 224 / Wednesday, November 21, 2007 / Notices
participating facilities; (2) monitor
progress towards attaining the Healthy
People 2010 goal of 60% vaccination
coverage among healthcare personnel;
(3) monitor influenza vaccination
coverage by ward/unit of the facility or
occupational group so that areas or
groups with low vaccination rates can
be targeted for interventions; (4) monitor
adverse reactions related to receipt of
the vaccine or receipt of antiviral
medications; and (5) assess the
characteristics of influenza vaccination
programs pre- and post-influenza season
to identify practices associated with
high immunization rates.
CDC is proposing to add an additional
form, Central Line Insertion Practices
Monitoring Form, to the Patient Safety
Component Device Associated Module.
This new form will enable participating
facilities and CDC to (1) monitor central
line insertion practices in individual
patient care units and facilities and
provide aggregate data for all
participating facilities (facilities have
the option of recording inserter-specific
adherence data); (2) link gaps in
recommended practice with the clinical
outcome both in individual facilities
and for all participating facilities; (3)
facilitate quality improvement by
identifying specific gaps in adherence to
recommended prevention practices,
thereby helping to target intervention
strategies for reducing central line
infection rates.
CDC proposes to add the Multi-Drug
Resistant Organism (MDRO) Prevention
Process Monitoring Module to the
Patient Safety Component. This module
consists of four forms: (1) MDRO
65579
regard to the number of high risk
patients receiving vaccination, those
already vaccinated, and those who
decline due to medical
contraindications or other reasons; and
(2) to identify reasons that high risk
patients are not receiving influenza
vaccination.
CDC is also proposing to open
enrollment to any healthcare facility;
therefore this submission includes a
registration form (Registration Form) to
collect necessary registration
information.
Finally, CDC also proposes to make
minor edits and modifications to
currently approved forms. The NHSN is
currently approved for 65,817 hours for
these forms.
CDC is also adding an increased
number of participating healthcare
institutions from a wide spectrum of
settings. Part of this increase in burden
hours is due to the passage of legislation
in many states requiring mandatory
reporting of healthcare-associated
infections. Some states plan to use are
or using NHSN as their data collection
system to meet this mandate.
Participating institutions must have a
computer capable of supporting an
Internet service provider (ISP) and
access to an ISP. The only other cost to
respondents is their time to complete
the appropriate forms.
The National Healthcare Safety
Network is currently approved for
65,817 burden hours. This revision is
seeking an increase of 1,212,498 burden
hours The total estimated annualized
burden hours are 1,278,315.
Prevention Process Monitoring Form; (2)
MDRO Infection Event Form; (3)
Laboratory-identified MDRO Event
Form; and (4) Laboratory-identified
MDRO Event Summary Form. The
purpose of these forms is to: (1) Monitor
processes and practices in individual
patient care units and facilities and to
provide aggregate adherence data for all
participating facilities; (2) link gaps in
recommended practice with the clinical
outcome (i.e., MDRO infection) both in
individual facilities and for all
participating facilities; (3) facilitate
quality improvement by identifying
specific gaps in adherence to
recommended prevention practices,
thereby helping to target intervention
strategies for reducing MDRO infection
rates.
The fourth new proposed collection to
the NHSN is the High Risk Inpatient
Influenza Vaccination Module. This
module consists of five forms: (1)
Influenza High Risk Inpatient Influenza
Vaccine Summary Form—Method A; (2)
Influenza High Risk Inpatient Influenza
Vaccine Summary Form—Numerator
Data Form Method B; (3) Influenza High
Risk Inpatient Influenza Vaccine
Summary Form—Method B; (4)
Influenza High Risk Inpatient Influenza
Vaccine—Denominator Form Method B;
and (5) High Risk Inpatient Influenza
Vaccination Standing Orders Form. The
last form is an optional form that may
be used in NHSN, but is not required as
part of the High Risk Patient Influenza
Vaccination module. The purpose of
these forms is to: (1) Monitor influenza
vaccination practices for high risk
patients and provide aggregate data in
ESTIMATE OF ANNUALIZED BURDEN HOURS
No. of
respondents
pwalker on PROD1PC71 with NOTICES
Form
A. Patient Safety Monthly Reporting Plan .................................................................
AA. Healthcare Worker Survey .................................................................................
B. Healthcare Personnel Safety Reporting Plan .......................................................
BB. Dialysis Survey ...................................................................................................
CC. List of Blood Isolates+ ........................................................................................
D. Primary Bloodstream Infection (BSI)** ..................................................................
DD. Manual Categorization of Positive Blood Cultures+ ...........................................
E. Dialysis Event ........................................................................................................
FF. Healthcare Worker Influenza Vaccination ...........................................................
G. Pneumonia (PNEU) (Includes decision algorithms: .............................................
Ga. Any Patient—Pneumonia Flow Diagram
Gb. Infant and Children—Pneumonia Flow Diagram)
GG. Healthcare Worker Influenza Antiviral Medication Administration .....................
H. Urinary Tract Infection (UTI) .................................................................................
HH. Preseason Survey on Influenza Vaccination Programs for Healthcare Personnel .....................................................................................................................
II. Postseason Survey on Influenza Vaccination Programs for Healthcare Personnel .....................................................................................................................
J. Denominators for Neonatal Intensive Care Units (NICU) .....................................
JJ. Central Line Insertion Practices Adherence Monitoring Form ............................
K. Denominators for Specialty Care Area (SCA) ......................................................
KK. Laboratory Testing ..............................................................................................
L. Denominators for Intensive Care Units (ICU)/Other locations (not NICU or SCA)
VerDate Aug<31>2005
16:56 Nov 20, 2007
Jkt 214001
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Average no.
of responses
per respondent
Average burden
per response
(in hours)
1,500
150
150
80
1,500
1,500
1,500
80
150
1,500
9
100
9
1
1
36
1
200
500
72
35/60
10/60
10/60
1
1
30/60
1
15/60
10/60
30/60
150
1,500
50
27
10/60
30/60
150
1
10/60
150
1,500
1,500
1,500
150
1,500
1
9
100
9
100
18
10/60
4
5/60
5
15/60
5
E:\FR\FM\21NON1.SGM
21NON1
65580
Federal Register / Vol. 72, No. 224 / Wednesday, November 21, 2007 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
No. of
respondents
Form
LL. Multi-drug Resistant Organism (MDRO) Prevention Process and Outcome
Measures Monthly Monitoring Form ......................................................................
M. Denominator for Outpatient Dialysis ....................................................................
MM. MDRO Infection Form .......................................................................................
N. Surgical Site Infection (SSI) ..................................................................................
NN. Laboratory-identified MDRO Event ....................................................................
O. Denominator for procedure ...................................................................................
OO. NHSN Registration Form ...................................................................................
P. Antimicrobial Use and Resistance (AUR)—Microbiology Laboratory Data** ........
PP. High Risk Inpatient Influenza Vaccination Monthly Monitoring Form—Method
A .............................................................................................................................
Q. Antimicrobial Use and Resistance (AUR)—Pharmacy Data** ..............................
QQ. High Risk Inpatient Influenza Vaccination Numerator Data Form—Method B
R. Facility Contact Information ..................................................................................
RR. High Risk Inpatient Influenza Vaccination Monthly Monitoring Form—Method
B .............................................................................................................................
S. Patient Safety Component Annual Facility Survey ...............................................
SS. High Risk Inpatient Influenza Vaccination Denominator Data Form—Method B
T. Agreement to Participate and Consent .................................................................
TT. Laboratory-identified MDRO Event Summary Form ...........................................
U. Group Contact Information ...................................................................................
V. Exposure to Blood/Body Fluids .............................................................................
W. Healthcare Worker Post-exposure Prophylaxis ...................................................
X. Healthcare Worker Demographic Data .................................................................
Y. Healthcare Worker Vaccination History ................................................................
Z. Implementation of Engineering (safety device) Controls for Sharps Injury Prevention ....................................................................................................................
Za. Healthcare Personnel Safety Component Facility Survey ..................................
** Burden
+ Burden
Average burden
per response
(in hours)
1,500
80
1,500
1,500
1,500
1,500
1,500
1,500
24
9
72
27
240
540
1
45
10/60
5/60
30/60
30/60
30/60
8/60
5/60
3
1,500
1,500
500
1,500
5
36
250
1
16
2
10/60
10/60
500
1,500
500
1,500
1,500
1,500
150
150
150
150
5
1
250
1
3
1
50
10
200
300
4
30/60
5/60
15/60
1
5/60
1
15/60
20/60
10/60
150
150
1
1
30/60
8
will be eliminated when reporting these data once an NHSN institution implements electronic data capture.
during validation phase only, then eliminated.
Dated: November 14, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–22731 Filed 11–20–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention: Notice of
Charter Renewal
pwalker on PROD1PC71 with NOTICES
Average no.
of responses
per respondent
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Committee on Childhood Lead
Poisoning Prevention, Centers for
Disease Control and Prevention of the
Department of Health and Human
Services, has been renewed for a 2-year
period extending through October 31,
2009.
For further information, contact Mary
Jean Brown, R.N., Sc.D., Executive
Secretary, Advisory Committee on
Childhood Lead Poisoning Prevention,
Centers for Disease Control and
Prevention of the Department of Health
VerDate Aug<31>2005
16:56 Nov 20, 2007
Jkt 214001
and Human Services, 4470 Buford
Highway, M/S F40, Atlanta, Georgia
30341, telephone 770/488–7492 or fax
770–488–3635.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: November 14, 2007.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E7–22722 Filed 11–20–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
Coordinating Center for Infectious
Diseases: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
463) of October 6, 1972, that the Board
of Scientific Counselors, Coordinating
Center for Infectious Diseases, Centers
for Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through October 31, 2009.
For information, contact Janet
Nicholson, Ph.D., Executive Secretary,
Board of Scientific Counselors,
Coordinating Center for Infectious
Diseases, Centers for Disease Control
and Prevention, Department of Health
and Human Services, 1600 Clifton Road,
NE., Mailstop D10, Atlanta, Georgia
30333, telephone 404/639–2100 or fax
404/639–2170.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: November 14, 2007.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E7–22772 Filed 11–20–07; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 72, Number 224 (Wednesday, November 21, 2007)]
[Notices]
[Pages 65578-65580]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-22731]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-07-0666]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
National Healthcare Safety Network (OMB Control No. 0920-0666)--
Revision--National Center for Preparedness, Detection and Control of
Infectious Diseases (NCPDCID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Healthcare Safety Network (NHSN) is a system designed
to accumulate, exchange, and integrate relevant information and
resources among private and public stakeholders to support local and
national efforts to protect patients and to promote healthcare safety.
Specifically, the data is used to determine the magnitude of various
healthcare-associated adverse events and trends in the rates of these
events among patients and healthcare workers with similar risks. The
data will be used to detect changes in the epidemiology of adverse
events resulting from new and current medical therapies and changing
risks.
Healthcare institutions that participate in NHSN voluntarily report
their data to CDC using a web browser-based technology for data entry
and data management. Data are collected by trained surveillance
personnel using written standardized protocols. This application to OMB
includes a significant increase in the number of burden hours to the
previously approved data collection. The increase is due to inclusion
of new forms and an increased number of respondents.
NHSN was first approved by OMB in 2005 and CDC proposes to revise
this data collection by adding new modules to the NHSN as well as
modifying currently approved forms. Four new forms are proposed: (1)
Healthcare Worker Influenza Vaccination form; (2) Healthcare Worker
Influenza Antiviral Medication Administration form; (3) Pre-season
survey on Influenza Vaccination Programs for Healthcare Workers; and
(4) Post-season Survey on Influenza Vaccination Programs for Healthcare
Workers. The purpose of these new forms is to help participating
healthcare institutions and CDC to: (1) Monitor influenza vaccination
coverage among healthcare personnel at individual facilities and to
provide aggregate coverage estimates for all
[[Page 65579]]
participating facilities; (2) monitor progress towards attaining the
Healthy People 2010 goal of 60% vaccination coverage among healthcare
personnel; (3) monitor influenza vaccination coverage by ward/unit of
the facility or occupational group so that areas or groups with low
vaccination rates can be targeted for interventions; (4) monitor
adverse reactions related to receipt of the vaccine or receipt of
antiviral medications; and (5) assess the characteristics of influenza
vaccination programs pre- and post-influenza season to identify
practices associated with high immunization rates.
CDC is proposing to add an additional form, Central Line Insertion
Practices Monitoring Form, to the Patient Safety Component Device
Associated Module. This new form will enable participating facilities
and CDC to (1) monitor central line insertion practices in individual
patient care units and facilities and provide aggregate data for all
participating facilities (facilities have the option of recording
inserter-specific adherence data); (2) link gaps in recommended
practice with the clinical outcome both in individual facilities and
for all participating facilities; (3) facilitate quality improvement by
identifying specific gaps in adherence to recommended prevention
practices, thereby helping to target intervention strategies for
reducing central line infection rates.
CDC proposes to add the Multi-Drug Resistant Organism (MDRO)
Prevention Process Monitoring Module to the Patient Safety Component.
This module consists of four forms: (1) MDRO Prevention Process
Monitoring Form; (2) MDRO Infection Event Form; (3) Laboratory-
identified MDRO Event Form; and (4) Laboratory-identified MDRO Event
Summary Form. The purpose of these forms is to: (1) Monitor processes
and practices in individual patient care units and facilities and to
provide aggregate adherence data for all participating facilities; (2)
link gaps in recommended practice with the clinical outcome (i.e., MDRO
infection) both in individual facilities and for all participating
facilities; (3) facilitate quality improvement by identifying specific
gaps in adherence to recommended prevention practices, thereby helping
to target intervention strategies for reducing MDRO infection rates.
The fourth new proposed collection to the NHSN is the High Risk
Inpatient Influenza Vaccination Module. This module consists of five
forms: (1) Influenza High Risk Inpatient Influenza Vaccine Summary
Form--Method A; (2) Influenza High Risk Inpatient Influenza Vaccine
Summary Form--Numerator Data Form Method B; (3) Influenza High Risk
Inpatient Influenza Vaccine Summary Form--Method B; (4) Influenza High
Risk Inpatient Influenza Vaccine--Denominator Form Method B; and (5)
High Risk Inpatient Influenza Vaccination Standing Orders Form. The
last form is an optional form that may be used in NHSN, but is not
required as part of the High Risk Patient Influenza Vaccination module.
The purpose of these forms is to: (1) Monitor influenza vaccination
practices for high risk patients and provide aggregate data in regard
to the number of high risk patients receiving vaccination, those
already vaccinated, and those who decline due to medical
contraindications or other reasons; and (2) to identify reasons that
high risk patients are not receiving influenza vaccination.
CDC is also proposing to open enrollment to any healthcare
facility; therefore this submission includes a registration form
(Registration Form) to collect necessary registration information.
Finally, CDC also proposes to make minor edits and modifications to
currently approved forms. The NHSN is currently approved for 65,817
hours for these forms.
CDC is also adding an increased number of participating healthcare
institutions from a wide spectrum of settings. Part of this increase in
burden hours is due to the passage of legislation in many states
requiring mandatory reporting of healthcare-associated infections. Some
states plan to use are or using NHSN as their data collection system to
meet this mandate.
Participating institutions must have a computer capable of
supporting an Internet service provider (ISP) and access to an ISP. The
only other cost to respondents is their time to complete the
appropriate forms.
The National Healthcare Safety Network is currently approved for
65,817 burden hours. This revision is seeking an increase of 1,212,498
burden hours The total estimated annualized burden hours are 1,278,315.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average no. of Average burden
Form No. of responses per per response (in
respondents respondent hours)
----------------------------------------------------------------------------------------------------------------
A. Patient Safety Monthly Reporting Plan............... 1,500 9 35/60
AA. Healthcare Worker Survey........................... 150 100 10/60
B. Healthcare Personnel Safety Reporting Plan.......... 150 9 10/60
BB. Dialysis Survey.................................... 80 1 1
CC. List of Blood Isolates\+\.......................... 1,500 1 1
D. Primary Bloodstream Infection (BSI)\**\............. 1,500 36 30/60
DD. Manual Categorization of Positive Blood Cultures\+\ 1,500 1 1
E. Dialysis Event...................................... 80 200 15/60
FF. Healthcare Worker Influenza Vaccination............ 150 500 10/60
G. Pneumonia (PNEU) (Includes decision algorithms:..... 1,500 72 30/60
Ga. Any Patient--Pneumonia Flow Diagram
Gb. Infant and Children--Pneumonia Flow Diagram)
GG. Healthcare Worker Influenza Antiviral Medication 150 50 10/60
Administration........................................
H. Urinary Tract Infection (UTI)....................... 1,500 27 30/60
HH. Preseason Survey on Influenza Vaccination Programs 150 1 10/60
for Healthcare Personnel..............................
II. Postseason Survey on Influenza Vaccination Programs 150 1 10/60
for Healthcare Personnel..............................
J. Denominators for Neonatal Intensive Care Units 1,500 9 4
(NICU)................................................
JJ. Central Line Insertion Practices Adherence 1,500 100 5/60
Monitoring Form.......................................
K. Denominators for Specialty Care Area (SCA).......... 1,500 9 5
KK. Laboratory Testing................................. 150 100 15/60
L. Denominators for Intensive Care Units (ICU)/Other 1,500 18 5
locations (not NICU or SCA)...........................
[[Page 65580]]
LL. Multi-drug Resistant Organism (MDRO) Prevention 1,500 24 10/60
Process and Outcome Measures Monthly Monitoring Form..
M. Denominator for Outpatient Dialysis................. 80 9 5/60
MM. MDRO Infection Form................................ 1,500 72 30/60
N. Surgical Site Infection (SSI)....................... 1,500 27 30/60
NN. Laboratory-identified MDRO Event................... 1,500 240 30/60
O. Denominator for procedure........................... 1,500 540 8/60
OO. NHSN Registration Form............................. 1,500 1 5/60
P. Antimicrobial Use and Resistance (AUR)--Microbiology 1,500 45 3
Laboratory Data\**\...................................
PP. High Risk Inpatient Influenza Vaccination Monthly 1,500 5 16
Monitoring Form--Method A.............................
Q. Antimicrobial Use and Resistance (AUR)--Pharmacy 1,500 36 2
Data\**\..............................................
QQ. High Risk Inpatient Influenza Vaccination Numerator 500 250 10/60
Data Form--Method B...................................
R. Facility Contact Information........................ 1,500 1 10/60
RR. High Risk Inpatient Influenza Vaccination Monthly 500 5 4
Monitoring Form--Method B.............................
S. Patient Safety Component Annual Facility Survey..... 1,500 1 30/60
SS. High Risk Inpatient Influenza Vaccination 500 250 5/60
Denominator Data Form--Method B.......................
T. Agreement to Participate and Consent................ 1,500 1 15/60
TT. Laboratory-identified MDRO Event Summary Form...... 1,500 3 1
U. Group Contact Information........................... 1,500 1 5/60
V. Exposure to Blood/Body Fluids....................... 150 50 1
W. Healthcare Worker Post-exposure Prophylaxis......... 150 10 15/60
X. Healthcare Worker Demographic Data.................. 150 200 20/60
Y. Healthcare Worker Vaccination History............... 150 300 10/60
Z. Implementation of Engineering (safety device) 150 1 30/60
Controls for Sharps Injury Prevention.................
Za. Healthcare Personnel Safety Component Facility 150 1 8
Survey................................................
----------------------------------------------------------------------------------------------------------------
\**\ Burden will be eliminated when reporting these data once an NHSN institution implements electronic data
capture.
\+\ Burden during validation phase only, then eliminated.
Dated: November 14, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-22731 Filed 11-20-07; 8:45 am]
BILLING CODE 4163-18-P
